Since LN18 and U87MG cells are both responsive to HRK overexpression and TRAIL treatment, they might be categorized under Type II cells and the apoptotic mechanisms regulated by HRK in such tumor cell types might be different than that of A172 cell like Type I cells. This evidence concerns the gene HRK and neoplasm.